Laboratorios Farmaceuticos Rovi, S.A. (0ILL.L)

84.30 +1.75 (+2.12%) At close: 05:01PM BST

Laboratorios Farmaceuticos Rovi, S.A.

Calle José Isbert, 2
Pozuelo de Alarcón
Madrid 28223
Spain
34 91 021 30 00
https://www.rovi.es

Sector(s): 
Industry: 
Full-time employees: 1,925

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Ivan Lopez-Belmonte Encina	Second Deputy Chairman & GM of Commercial and Development	472k	N/A	N/A
Mr. Javier Lopez-Belmonte Encina	First Deputy Chairman, GM of Industrial Operations & CFO	474k	N/A	N/A
Mr. Juan Lopez-Belmonte Encina	Chairman & CEO	1.15M	N/A	N/A
Marta Campos Martínez	Head of Investor Relations	N/A	N/A	N/A
Ms. Mercedes Benítez del Castillo Sánchez	Legal Department Manager	N/A	N/A	N/A
Ms. Beatriz Ávila Alcalde	Sales Manager	N/A	N/A	N/A
Ms. Rosario Perucha Pérez	Marketing Manager	N/A	N/A	N/A
Mr. Francisco Javier Angulo García	Human Resources Manager	N/A	N/A	N/A
Mr. Gabriel Nunez Fernandez	Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.

Corporate governance

Laboratorios Farmaceuticos Rovi, S.A.’s ISS governance QualityScore as of 29 April 2024 is 3. The pillar scores are Audit: 8; Board: 7; Shareholder rights: 7; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.